ISSN 1812-7231 Klin.inform.telemed. Volume 13, Issue 14, 2018, Pages 28–31
N. Marchitto1, E. Bergamini1, C. Di Febbo2, A. Ciaramella3, G. Raimondi3
1Alfredo Fiorini Hospital, Terracina, Latina, Italy
2UOC Internal Medicine Department Universitа G. D'Annunzio Chieti, Italy
3Dept. of Medico-Surgical Sciences and Biotechnologies. "Sapienza" University of Roma
Control of water in the organism of elderly patients with severe chronic heart failure based on bioelectrical impedance analysis
Introduction. Heart failure (HF) is defined as an abnormality of the cardiac structure and/or function resulting in clinical symptoms (dyspnoea) and signs (edema), poor quality of life and shortened survival . Currently, the correlations between heart failure with reduced ejection fraction (EF) (HFrEF) and Bioelectrical impedance analysis (BIA) have been only scantly investigated.
Aim. The aim of this study is the evaluation of the possible role of Bioelectrical impedance analysis in patients with severe chronic heart failure.
Materials and Methods. We evaluated 30 elderly patients: 22 were males (mean age 77 ± 8 years) and 8 females (mean age 60 ± 10 years) with HFrEF at baseline electrocardiograph evaluation. All patients were classified as New York Heart Association (NYHA) class III at baseline and provided an informed consent.
Results. At the end of the observation period, therapy with sacubitril/valsartan was associated with improved redistribution of body water and extracellular mass (19, 4 ± 3, 0 at baseline vs 18, 4 ± 2, 6 Kg/m at 1 month, p = 0, 001) and body weight reduction (81 ± 8 vs 78 ± 8 Kg, p = 0, 002). Overall, this therapy resulted in a prompt (1 month) amelioration in the distribution of body water and decreased body weight, as well as improved clinical outcomes (dyspnoea) at physical examination.
Conclusion. In this small case series, we investigated the correlation between sacubitril/valsartan and body water modification in elderly patients with HFrEF. Our preliminary data show that Bioelectrical impedance analysis could be a new effective approach in the evaluation and follow-up of elderly patients with chronic heart failure and reduced ejection fraction.
Chronic Heart Failure, Bioelectrical impedance analysis (BIA), water body composition, Impedance, Reactance
1. Senni M, Trimarco B, Emdin M, et al. Sacubitril/valsartan, a new and effective treatment for heart failure with reduced ejection fraction. G. Ital. Cardiol. (Rome), 2017, vol. 18, iss. 1, pp. 3–11.
2. Krittanawong C., Kitai T. Pharmacogenomics of Angiotensin-Receptor/Neprilysin Inhibitor and its Long-Term Side Effects. Cardiovasc Ther., 2017, vol. 35, no. 4.
3. Yancy C. W., Jessup M., Bozkurt B., et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Manag ement of Heart Failure: A Report of the American College of Cardiology/America Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J. Card. Fail., 2017, vol. 23, iss. 8, pp. 628–651.
4. Peruzzi G., Di Nardo P., Raimondi G., Legramante J. M., et. al. The physiopathological aspects and new therapeutic approaches in cardiac-circulatory failure. Clin. Ter., 1992, vol. 141, no. 11, pp. 339–372.
5. Thomasset A. Bio-electrical properties of tissue impedance measurements. Lyon Med., 1962, iss. 207, pp. 107–118.
6. Nyboer J. Electrical Impedance Plethysmography. In: The Electrical Resistive Measure of the Blood Pulse Volume, Peripheral and Central Blood Flow. Springfield, IL: Charles C. Thomas. 1959.
7. Hoffer E. C., Meador C. K., and Simpson D. C. Correlation of whole-body impedance with total body water volume. J. Appl. Physiol. 1969, vol. 27, pp. 531–534.
Full-text version http://kit-journal.com.ua/en/viewer_en.html?doc/2018_14/003.pdf